Immutep (IMMP) Operating Expenses (2015 - 2017)
Immutep's (IMMP) quarterly Operating Expenses came in at $14.9 million in Q2 2017, down 19.5% YoY from $18.5 million in Q2 2016, and up 736.63% on a QoQ basis from -$2.3 million in Q1 2017.
Immutep (IMMP) Operating Expenses (2015 - 2017) Analysis & Trends
Immutep (IMMP) has 3 years of Operating Expenses data on file, last reported at $14.9 million in Q2 2017.
- Quarterly Operating Expenses fell 19.5% year-over-year to $14.9 million in Q2 2017, while the trailing twelve-month figure through Jun 2019 was $14.9 million (up 18.63% YoY) and the FY2025 annual result came in at $5.5 million, down 5.11% from the prior year.
- Operating Expenses improved to $14.9 million in Q2 2017, from -$2.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $18.5 million in Q2 2016 to a low of -$6.2 billion in Q2 2015.
- A 3-year average of -$1.2 billion and a median of -$1.8 million in 2016 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2016 — Operating Expenses jumped 100.3% — and 2017, when it slipped 29.98%.
- Tracing IMMP's Operating Expenses over 3 years: stood at -$6.2 billion in 2015, then jumped by 100.3% to $18.5 million in 2016, then declined by 19.5% to $14.9 million in 2017.
- The last three Operating Expenses figures came in at $14.9 million (Q2 2017), -$2.3 million (Q1 2017), and $18.5 million (Q2 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Immutep | 57.14 Mn | -7.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 14.86 Mn |
| Mar 31, 2017 | -2.33 Mn |
| Jun 30, 2016 | 18.46 Mn |
| Mar 31, 2016 | -1.80 Mn |
| Jun 30, 2015 | -6.16 Bn |